Microbiological characteristics andclinical efficacy of phosphomycin
- Авторлар: Loran ОВ1, Strachunsky LS1, Sinyakova LA1, Rafalsky VV1, Shevelev AN1, Kosova IV1
-
Мекемелер:
- Шығарылым: № 3 (2004)
- Беттер: 18-21
- Бөлім: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/275234
- ID: 275234
Дәйексөз келтіру
Толық мәтін
Аннотация
E. coli is the most frequent agent causing urinary infection (UI)
both in adults and children. E. coli of UI outpatients is often resistant
to ampicilline, amoxicilline and co-trimoxasol.The study of phosphomycin
in UI outpatients showed its highest efficacy against E.coli.
Phosphomycin in a single daily dose of 3 g is a drug of choice in acute
uncomplicated cystitis.The results of the study also demonstrate that
phosphomycin can be used for prevention of pyoinflammatory complications
before endoscopic manipulations and operations as well as
open operations on the lower urinary tracts and genital organs
both in adults and children. E. coli of UI outpatients is often resistant
to ampicilline, amoxicilline and co-trimoxasol.The study of phosphomycin
in UI outpatients showed its highest efficacy against E.coli.
Phosphomycin in a single daily dose of 3 g is a drug of choice in acute
uncomplicated cystitis.The results of the study also demonstrate that
phosphomycin can be used for prevention of pyoinflammatory complications
before endoscopic manipulations and operations as well as
open operations on the lower urinary tracts and genital organs
Әдебиет тізімі
- Shrestha N. К., Tomford J. W. Fosfomycin: A review. Infectious Dis. Clin. Pract. 2001; 10: 255-260.
- Perri M. В., Hershberger E., Ionescu M. et al. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin. Diagn. Microbiol. Infect. Dis. 2002; 42 (4): 269-271.
- Data R., Gutierrez J., Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int. J. Antimicrob. Agents 2001; 18 (3): 211-215.
- Kahlmeter G. An International survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECOSENS project. J. Antimicrob. Chemother. 2003; 51: 69-76.
- Kahan F. M., Kahan J. S., Cassidy P. J., Kropp H. The mechanism of action fosfomycin (phosphonomycin). Ann. N. Y. Acad. Sci. 1974; 235: 364-386.
- Carlone N. A., Borsotto M., Cuffini A. M., Savoia D. Effect of fosfonomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents. Eur. Urol. 1987; 13 (suppl. 1): 86-91.
- Albini E., Arena E., Belluco C., Marca G. Adhesion of bacteria to human uroepithelial cells and bactericidal activity of fosfonomycin trometamolk. In: New trends in urinary tract infection: Int. symp. Rome, 1987. Basel: Karger; 1988. 250-254.
- Zhanel G. G., Nicolle L. E. Effect of subinhibitory antimicrobial concentrations (sub-MICs) on in-vitro bacterial adherence to uroepithelial cells. J. Antimicrob. Chemother. 1992; 29: 617-627.
- Аляев Ю. Г., Винаров А. З., Воскобойников В. Б. Острый цистит: этиология, клиника, лечение. Лечаший врач 2002; 4.
Қосымша файлдар
